Chemotherapy drugs that target cancer cells without damaging normal cells remain one of the key goals of precision medicine ...

Chemo 1: Will increase your life expectancy from 12 to 15 months. Chemo 2: Increases your chance of being alive at one year ...

A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate ...

For patients living with HER2-positive metastatic breast cancer, the recent FDA approval of trastuzumab deruxtecan (brand ...

Researchers at Johns Hopkins have found that chemotherapy drugs paclitaxel and carboplatin, used to treat cancer patients, ...

To throw away common medications, follow these steps: Mix it: Put the medicine in a container and mix it with something that ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the ...

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its proprietary PALM™ nanotechnology, today announced a major manufacturing ...

A combination of the antibody-drug conjugate enfortumab vedotin (Padcev) and the PD-1 inhibitor pembrolizumab (Keytruda) ...

The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...